Senseonics (NYSE:SENS) said today that it priced an underwritten offering of 29 million shares of common stock at $1.41 apiece to a group of institutional investors. Roche Finance agreed to purchase 21 million shares and New Enterprise Associates agreed to purchase 7 million shares in the offering, according to the Germantown, Md.-based company. Senseonics said […]
Diabetes
Welcome to MassDevice's Diabetes Hub, your resource for the latest news in diabetes technology. Stay informed about the innovations and business news shaping the diabetes device industry.
Here are top diabetes features from MassDevice and its sister publications (and scroll down to read the latest diabetes device news from MassDevice):
+ These diabetes devices are set to launch in 2024
+ The top IVD and diabetes tech stories of 2023
+ How Dexcom designed a new “life-changing” sensor for even more people with diabetes
+ Embecta CEO sees GLP-1 opportunities as company progresses on insulin patch pump
+ The 10 biggest diabetes tech stories from 2023
Latest Diabetes News
Artificial pancreas: These companies are racing to make one
Medical device companies are close to achieving the holy grail of diabetes treatment: a combined glucose sensor, control algorithm and insulin infusion device that effectively acts as an “artificial pancreas.” We explain more in the newest video from editors at MassDevice’s sister publication Medical Design & Outsourcing. (And for a deeper dive, check out our recent […]
Valeritas touts cost savings, real-world outcomes with V-Go insulin pump
In a retrospective analysis of 86 diabetic patients who switched from multiple daily insulin injections to the V-Go insulin pump, Valeritas (NSDQ:VLRX) reported this week that use of its device led to a 44% reduction in total daily insulin dose per patient. A drastic cut to a patient’s daily insulin dose and improvement to their blood sugar levels […]
GI Dynamics touts weight loss, lowered HbA1c in EndoBarrier meta-analysis
GI Dynamics (ASX:GID) yesterday released data from a meta-analysis of its EndoBarrier device, touting improved glycemic control in patients with type 2 diabetes and obesity. Data from the meta-analysis study was presented at the Digestive Disease Week meeting in Chicago. The EndoBarrier device from the Lexington, Mass.-based company is a plastic gut sleeve designed to prevent the absorption of […]
Fractyl Labs launches Revita DMR diabetic treatment study
Fractyl Laboratories said today it launched the Revita-2 clinical trial of its Revita DMR procedure in orally-treated type 2 diabetes patients with poorly controlled disease. The company said that it has enrolled the 1st patient in the trial at a European center participating in the study. The Revita DMR is a minimally invasive procedure designed to […]
ViaCyte looks to cell replacement therapy to cure Type I diabetes
ViaCyte said today that it will begin clinical trials of its novel islet cell replacement therapy in development as a potential cure for Type I diabetes, after landing regulatory wins from the FDA and Health Canada. The company’s PEC-Direct candidate delivers stem cell-derived pancreatic progenitor cells in a device that is designed to enable direct […]
Sanofi’s insulin biosimilar wins EMA committee recommendation
Sanofi (NYSE:SNY) said today that the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended its insulin lispro biosimilar for approval. Insulin lispro Sanofi is a biosimilar of insulin lispro, a fast-acting insulin analog made using recombinant DNA technology. Sanofi’s biosimilar has the exact same amino acid sequence as its reference product. The positive opinion […]
Nemaura touts data for Memspatch insulin micro-needle device
Nemaura Pharma‘s Memspatch insulin micro-needle device compared well against a pen injector in an 18-patient clinical trials, according to the company. The group of Type I diabetic patients were given insulin using either the Memspatch device or a traditional pen injector. Researchers evaluated the patient’s pain levels using a number pain rating score from 0 […]
CE Mark suspended for GI Dynamics EndoBarrier
GI Dynamics (ASX:GID) said yesterday that the CE Mark approval for its EndoBarrier device was suspended for “nonconformances” in its quality management system under European Union regulations. GI Dynamics president & CEO Scott Schorer told MassDevice.com today during a telephone interview that the suspension is not a recall and does not involve the safety or efficacy […]
Report: New Apple Watch could include glucose monitor, other health tech
Apple (NSDQ:AAPL) may be developing glucose monitoring capabilities for the next-generation version of its Apple Watch, according to a new BGR report which cites sources close to the company. The report claims that the company is working to implement the ability to monitor glucose with the Watch, possibly through the use of new interchangeable smart bands […]
Smart Meter wins FDA nod, CE Mark for iGlucose monitoring system
Diabetes-focused medical device developer Smart Meter said today it won FDA 510(k) clearance and CE Mark approval in the European Union for its iGlucose blood glucose monitoring system. The New York-based company’s iGlucose system is a subscription-free glucose meter and diabetes health managements system which automatically transmits data to a cloud-based personalized web portal. The system […]